Plus   Neg

Amarin Stock Down On Possible AdCom Meeting By FDA Related To Vascepa

In a SEC filing, Amarin Corporation plc (AMRN) stated that it is possible that the FDA will choose to conduct an AdCom meeting with respect to the company's sNDA seeking an expanded indication for Vascepa. Amarin said any delay in obtaining the expanded marketing approval could materially harm the company's business.

However, Amarin noted that the FDA has not yet informed Amarin whether it plans to hold an AdCom meeting.

Shares of Amarin were down more than 9% on the announcement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Whole Foods Market stores have recalled Decorated Red Apple Cookies as they may contain undeclared egg. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening allergic reaction if they consume these products. The cookies were sold by the... Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber... Amazon.com Inc. has expanded its AmazonFresh grocery delivery service to three new cities. Beginning today, Amazon Prime members in Houston, Minneapolis and Phoenix can shop thousands of products, ranging from meat and seafood to fresh produce and everyday essentials. The groceries will be delivered to their homes in two hours or less, with options for one-hour and two-hour delivery.
Follow RTT